Most lately, it has been discovered that conolidine and the above derivatives act around the atypical chemokine receptor three (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds to the big range of endogenous opioids. Compared with most opioid receptors, this receptor acts as being a scavenger and does not activate … Read More